Ditchcarbon
  • Customers
  1. Organizations
  2. Mayne Pharma
Public Profile
Pharmaceutical Preparation Manufacturing
AU
updated 10 days ago

Mayne Pharma

Company website

Mayne Pharma Group Limited, commonly referred to as Mayne Pharma, is a prominent Australian pharmaceutical company headquartered in Adelaide, South Australia. Founded in 1850, the company has established itself as a key player in the global pharmaceutical industry, focusing on the development and manufacturing of generic and specialty pharmaceuticals. With a strong presence in both the Australian and international markets, Mayne Pharma is renowned for its innovative drug delivery systems and high-quality generic medications. The company’s core offerings include a diverse range of oral and topical formulations, particularly in the areas of oncology, dermatology, and women's health. Mayne Pharma has achieved significant milestones, including strategic acquisitions and partnerships that have bolstered its market position. Its commitment to quality and innovation has earned it a reputation for excellence, making it a trusted name in the pharmaceutical sector.

DitchCarbon Score

How does Mayne Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

16

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Mayne Pharma's score of 16 is lower than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.

11%

Let us know if this data was useful to you

Mayne Pharma's reported carbon emissions

Mayne Pharma, headquartered in Australia, has reported its carbon emissions data for the years 2015 and 2016. In 2016, the company had a greenhouse gas (GHG) emissions intensity of approximately 0.0696 kg CO2e per AUD of revenue, while in 2015, this figure was about 0.0955 kg CO2e per AUD of revenue. However, specific absolute emissions figures for Scope 1, 2, and 3 are not disclosed, indicating a lack of detailed emissions reporting. Currently, Mayne Pharma does not have any publicly stated reduction targets or commitments under the Science Based Targets initiative (SBTi) or other climate pledges. The absence of such targets suggests that the company may be in the early stages of developing a comprehensive climate strategy. As of now, there is no cascaded emissions data from a parent or related organization, indicating that Mayne Pharma's emissions reporting is independent. The company is encouraged to enhance its transparency and set measurable climate commitments to align with industry standards and expectations.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Mayne Pharma's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Mayne Pharma is in AU, which has a very high grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Mayne Pharma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Arcutis Biotherapeutics, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 10 hours ago

Galderma

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Sun Pharmaceutical Industries

IN
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Domesco Medical Import - Export Joint-Stock Corporation

VN
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Journey Medical Corporation

US
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Leo Pharma

DK
•
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250807.8
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy